October 2020 Journal Club
Tuesday, October 13, 2 pm CDT
Tammy Li, PharmD presents Olaparib for Metastatic Castration-Resistant Prostate Cancer
Sarah Tu, PharmD presents Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Joe Kalis, PharmD was the moderator.
A recording of the live webinar is available in this course and will remain active for one year.
Please take the post-webinar survey to give feedback on the webinar using this link: https://www.hoparx.org/apps/october-2020-journal-club-evaluation/
SpeakersTammy Li, PharmD
PGY-2 Oncology Pharmacy Resident
M Health Fairview/University of Minnesota
This was a live webinar open to members and non-members. No credit is given for this education. If you have questions about Journal Club, please contact HOPA Education at email@example.com